FDA NDC Directory · JSON-LD · Markdown

Repaglinide

NDC 33342-248 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerMacleods Pharmaceuticals Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA207209
Dosage form / routeTABLET · ORAL
Active ingredientsREPAGLINIDE (.5 mg/1)
Marketing started20230322
Package count2

External sources

Source: openFDA. Public-domain (CC0).